A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy ...

High dividend yields are not always as great as they may seem. Remember that a dividend yield is arrived at by dividing a stock's annual dividend amount by its current stock price.

Given the number of comorbidities associated with obesity, the market's growth will impact the entire cardiometabolic disease ...

As the body of research expands on the potential of glucagon-like peptide-1 receptor agonists to address various health ...

Novo Nordisk announced plans for a longer phase III trial testing its investigational obesity drug CagriSema, with regulatory ...

Investing in stocks that aren't performing well can be a good move, but only if there are good reasons to think they will recover. That isn't the case for many companies that have lagged broader ...

AbbVie is a resurging Dividend King. Amgen's recent clinical setback makes its stock available at a discount. Gilead Sciences ...

We recently published a list of Jim Cramer Discussed 10 Stocks Leading the Dow Higher in 2025. In this article, we are going ...

Amgen's dividend yield remains attractive, with a moderate payout ratio and strong free cash flow. Click here to see why AMGN ...

CNBC’s Jim Cramer on Thursday thought it worthwhile to review ten stocks that led the Dow Jones Industrial Average over the ...

All of a sudden, Amgen stock is up 15% since late December to around $299. Its rise helped push up the healthcare sector up ...